MO255LONG-TERM MAINTENANCE TREATMENT WITH RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE COHORT STUDY | Nephrology Dialysis Transplantation | 2021 | 78 |
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database | Annals of the Rheumatic Diseases | 2021 | 33 |
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases | Annals of the Rheumatic Diseases | 2021 | 11 |
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2021 | 11 |
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study | Rheumatology International | 2021 | 9 |
Age- and sex-based differences in patients with acute pericarditis | European Journal of Clinical Investigation | 2021 | 9 |
Adamantiades-Behçet's disease (Behçet's disease) and COVID-19 | Journal of the European Academy of Dermatology and Venereology | 2021 | 8 |
The Effect of Antioxidant and Anti-Inflammatory Capacity of Diet on Psoriasis and Psoriatic Arthritis Phenotype: Nutrition as Therapeutic Tool? | Antioxidants | 2021 | 8 |
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States | Vaccine | 2021 | 7 |
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study | Rheumatology | 2021 | 7 |
Changes in Stroke Hospital Care During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis | Stroke | 2021 | 7 |
Inter-Variability Study of COVLIAS 1.0: Hybrid Deep Learning Models for COVID-19 Lung Segmentation in Computed Tomography | Diagnostics | 2021 | 6 |
The DNA damage response network in the treatment of head and neck squamous cell carcinoma | ESMO Open | 2021 | 6 |
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection | Clinical Immunology | 2021 | 6 |
Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience | Rheumatology | 2021 | 6 |
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus | Clinical Immunology | 2021 | 6 |
Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors | Arthritis and Rheumatology | 2021 | 6 |
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019 | RMD Open | 2021 | 5 |
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study | Rheumatology International | 2021 | 5 |
The Effects of Muscle Cell Aging on Myogenesis | International Journal of Molecular Sciences | 2021 | 5 |
Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction | Journal of Inflammation Research | 2021 | 5 |
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus | European Journal of Preventive Cardiology | 2021 | 4 |
Growth Differentiation Factor 15 (GDF-15) as potential cardiovascular risk biomarker in Antiphospholipid Syndrome | Rheumatology | 2021 | 4 |
A risk score for pericarditis recurrence | European Journal of Clinical Investigation | 2021 | 4 |
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit | RMD Open | 2021 | 4 |